EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of Safety Biomarkers for Autologous Blood Transfusion in Hepatocellular Carcinoma Patients

Yong Cheng, Yue Wang, Xiao-Fang Zhou, Lai-Wei You, Xiao-Yi Xie, Hao Li, Mandi Wu, Jianrong Guo iD

Journal of Cellular and Molecular Medicine · 2025

DOI: 10.1111/jcmm.70504 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Yong Cheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Gongli Hospital of Shanghai Pudong New Area, Shanghai, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Blood Transfusion, Autologous, Biomarkers, Tumor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, Pudong New Area Science and Technology Development Fund in Shanghai, Key Disciplines Group Construction Project of Pudong Health Bureau of Shanghai.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) represents the predominant form of primary liver cancer, constituting 75%–85% of all liver cancer cases. Despite advances in understanding HCC mechanisms and treatment options, challenges remain and further research is needed to uncover new therapeutic targets and improve patient outcomes. intraoperative cell salvage (IOCS) is an important surgical method that minimises the necessity for transfusions of donor blood, improves haemodynamic stability and may enhance recovery. This study aims to identify safety biomarkers for autologous blood transfusion in HCC patients. We conducted a prospective case–control study on 80 HCC patients undergoing radical surgery. Blood and tumour tissues were collected for analysis. The control group provided blood directly from the surgical site without IOCS processing, while the experimental group used blood collected through the IOCS system. Dual‐Luciferase reporter gene assays, immunofluorescence, Western blot and qRT‐PCR techniques were employed to assess the expression of key proteins and microRNAs. Comparable demographic and baseline clinical characteristics were observed between groups. The experimental group showed significantly improved pathological features, with an increase in PTEN‐positive cells and upregulated protein expression of PTEN, mTOR, c‐Met and IGF1R. Additionally, miRNA levels (miRNA‐21, miRNA‐122, miRNA‐223, miRNA‐199a and miRNA‐375) were significantly reduced in the experimental group ( p < 0.05), while mRNA levels for PTEN, mTOR, c‐Met, YAP1 and IGF1R were significantly upregulated ( p < 0.05). IOCS has a positive impact on liver tissue pathology in HCC patients by reducing apoptosis and modulating key molecular pathways. These findings suggest that IOCS could be a valuable therapeutic strategy for HCC, potentially guiding future treatment approaches and improving patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsBlood Transfusion, AutologousBiomarkers, TumorHumansMaleFemaleMiddle AgedMicroRNAsCase-Control StudiesProspective StudiesAgedGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

autologous blood transfusionhepatocellular carcinomasafety biomarkers

Substanzen

MicroRNAsBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Anesthesiology, Gongli Hospital of Shanghai Pudong New Area, Shanghai, China.

ORCID-Profile: Jianrong Guo

Förderung

  • the National Natural Science Foundation of China
  • Pudong New Area Science and Technology Development Fund in Shanghai
  • Key Disciplines Group Construction Project of Pudong Health Bureau of Shanghai

Zitieren

APA

Cheng, Y., Wang, Y., Zhou, X. F., You, L. W., Xie, X. Y., Li, H., Wu, M., & Guo, J. (2025). Identification of Safety Biomarkers for Autologous Blood Transfusion in Hepatocellular Carcinoma Patients. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70504

Vancouver

Cheng Y, Wang Y, Zhou XF, You LW, Xie XY, Li H, et al. Identification of Safety Biomarkers for Autologous Blood Transfusion in Hepatocellular Carcinoma Patients. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70504

BibTeX
@article{Cheng2025,
  author = {Cheng, Yong and Wang, Yue and Zhou, Xiao-Fang and You, Lai-Wei and Xie, Xiao-Yi and Li, Hao and Wu, Mandi and Guo, Jianrong},
  title = {Identification of Safety Biomarkers for Autologous Blood Transfusion in Hepatocellular Carcinoma Patients},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2025},
  doi = {10.1111/jcmm.70504}
}
Kostenlos starten →